BioAge Labs (BIOA) Receivables - Accured (2024 - 2026)

BioAge Labs has disclosed Receivables - Accured across 3 years of filings, most recently posting $2.5 million for Q2 2026.

• In Q2 2026, Receivables - Accured rose 150.0% year-over-year to $2.5 million; the TTM figure through Jun 2026 stood at $2.5 million (up 150.0% YoY), while the FY2025 annual figure was $1.2 million, changed 0.0% from the prior year.
• Receivables - Accured came in at $2.5 million for Q2 2026 at BioAge Labs, up from $1.9 million in the prior quarter.
• In the past five years, Receivables - Accured ranged from a high of $2.5 million in Q2 2026 to a low of $1.0 million in Q2 2025.
• Average Receivables - Accured over 3 years is $1.4 million, with a median of $1.2 million recorded in 2024.
• Year-over-year, Receivables - Accured changed 0.0% in 2025 and jumped 150.0% in 2026.
• Over 3 years, Receivables - Accured stood at $1.2 million in 2024, then changed by 0.0% to $1.2 million in 2025, then surged by 108.33% to $2.5 million in 2026.
• Per Business Quant data, the three most recent Receivables - Accured figures were $2.5 million in Q2 2026, $1.9 million in Q1 2026, and $1.2 million in Q4 2025.